Keywords: saruplase, set, spring, launch, gruenenthal, new, fibrin-specific
Saruplase Set For Spring 1998 Launch
Article | 25 November 1997
Gruenenthal's new fibrin-specific thrombolytic saruplase (recombinantpro-urokinase) should be launched onto the market in the spring of 1998, said a spokesman for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
